Shutting the Door on Cancer Cells

Concarlo Therapeutics is developing a drug that could transform the way we treat cancer. In this episode, Co-founder, Chief Scientific Officer, and acting CEO of Concarlo Therapeutics, Dr. Stacy Blain,shares her journey of researching, testing and securing funding for a drug that kills off cancer cells. Join us as we discuss:

• Clinical grade manufacturing processes
• FDA regulations and clinical trials
• Cancer cell proliferation and necrosis